Cheyne Capital Management UK LLP bought a new position in shares of RAPT Therapeutics, Inc. ( NASDAQ:RAPT – Get Rating ) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 71,828 shares of the company's stock, valued at approximately $1,422,000. RAPT Therapeutics accounts for approximately 2.5% of Cheyne Capital Management UK LLP's investment portfolio, making the stock its 9th largest holding.

https://www.dailypolitical.com/2023/05/21/cheyne-capital-management-uk-llp-makes-new-investment-in-rapt-therapeutics-inc-nasdaqrapt.html

#dailypolitical